Broncotron-D (dextromethorphan / guaifenesin / phenylephrine) Drug Interactions
A total of 843 drugs (4637 brand and generic names) are known to interact with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine).
- 217 major drug interactions (1527 brand and generic names)
- 621 moderate drug interactions (3097 brand and generic names)
- 5 minor drug interactions (13 brand and generic names)
Check for interactions with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine)
Common medications checked in combination with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine)
- albuterol
- Children's Claritin Allergy (loratadine)
- Children's Tylenol (acetaminophen)
- Chlorpheniramine (Allergy) (chlorpheniramine)
- Cloderm (clocortolone topical)
- cromolyn
- Flintstones with C Multivitamins (multivitamin)
- itraconazole
- metronidazole
- montelukast
- nystatin / triamcinolone topical
- Panadol (acetaminophen)
- Paracetamol (acetaminophen)
- Pentasa (mesalamine)
- prednisolone
- Pristiq (desvenlafaxine)
- propranolol
- Qvar (beclomethasone)
- Singulair (montelukast)
- zolpidem
Broncotron-D (dextromethorphan / guaifenesin / phenylephrine) alcohol/food Interactions
There is 1 alcohol/food interaction with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine)
Broncotron-D (dextromethorphan / guaifenesin / phenylephrine) disease Interactions
There are 5 disease interactions with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine) which include:
More about Broncotron-D (dextromethorphan / guaifenesin / phenylephrine)
- Broncotron-D Side Effects
- During Pregnancy
- Dosage Information
- En Español
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
